LH

367.1300.47%
JA

Julia A. Wang

Executive VP & CFO

Ms. Julia A. Wang is CFO & Executive VP of Labcorp Holdings Inc. from December 2, 2024. Ms. Julia Wang is Executive Vice President and Chief Financial Officer of Laboratory Corporation of America Holdings from February 2025. Ms. Wang had been Chief Financial Officer of BeiGene, Ltd. since June 30, 2021 until July 22, 2024 and served as Principal financial officer from March 19, 2024 until July 22, 2024 and served as its Principal Accounting Officer until March 19, 2024. She joined BeiGene in June 2020 and served as its Senior Vice President of Enterprise Optimization Deputy Chief Financial Officer since June 2020 until June 30, 2021. Ms. Wang has extensive global finance experience across biotech, pharmaceutical, medical devices, diagnostic testing and consumer products. She was Senior Vice President, Global Business Finance, Corporate Finance and Corporate FP&A at Alexion Pharmaceuticals and from 2018 to 2020. From 2015 to 2018, she held leadership positions at Quest Diagnostics, including Vice President of U.S. Regional Finance and Enterprise Commercial and Vice President of Finance, Value Creation. From 2007 to 2012, she held senior leadership roles at Johnson and Johnson (J&J) as Chief Financial Officer of various operating businesses, including Xian-Janssen, J&J’s pharmaceutical business in China. Prior to 2007, she led finance initiatives at PepsiCo. Ms. Wang received an MBA from Fuqua School of Business at Duke University in 1999 and a BA in British Language and Literature from Shandong Normal University in 1992.

Positions